Stool antigen-based enzyme immunoassays: performance evaluations and automation.

Area of Science:

• Clinical microbiology
• Diagnostic immunology

Background:

• Enzyme immunoassay (EIA) is a standard method for detecting gastrointestinal pathogens in stool samples.
• Accurate and efficient detection of Cryptosporidium, Giardia, and Campylobacter is crucial for diagnosing diarrhea diseases.

Purpose of the Study:

• To evaluate the performance of three EIAs for detecting Cryptosporidium, Giardia, and Campylobacter in stool samples.
• To assess the impact of automation (DS2 system) on the efficiency and cost-effectiveness of these EIAs.

Main Methods:

• Three EIAs were tested on two platforms each, comparing results to reference methods like direct fluorescent antibody (DFA) testing, microscopy, and culture.
• Automation of these EIAs and five others was evaluated on a DS2 system against manual methods.

Main Results:

• Cryptosporidium EIAs showed 100% agreement with DFA and high correlation with microscopy.
• Giardia EIAs had 100% positive concordance but moderate correlation with microscopy.
• Campylobacter EIAs demonstrated 93.5% sensitivity and 100% specificity.
• Automated EIAs achieved 92.5-100% accuracy and 100% precision, saving labor time for high-volume runs.

Conclusions:

• EIAs are reliable for detecting protozoan parasites in stool, with Cryptosporidium EIA showing potential as a semi-quantitative assay.
• Automation enhances efficiency in high-throughput laboratories but may not be cost-effective for low-volume settings.